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A549 cellsAdenovirus 11 prototype (Ad11p), belonging to species B, uses CD46 as an attachment receptor. CD46, a
complement regulatory molecule, is expressed on all human nucleated cells. We show here that Ad11p
virions downregulate CD46 on the surface of K562 cells as early as 5 min p.i. Speciﬁc binding to CD46 by the
Ad11p ﬁber knob was required to mediate downregulation. The complement regulatory factors CD55 and
CD59 were also reduced to a signiﬁcant extent as a consequence of Ad11p binding to K562 cells. In contrast,
binding of Ad7p did not result in downregulation of CD46 early in infection. Thus, the presumed interaction
between Ad7p and CD46 did not have the same consequences as the Ad11p–CD46 interaction, the latter
virus (Ad11p) being a promising gene therapy vector candidate. These ﬁndings may lead to a better
understanding of the pathogenesis of species B adenovirus infections.i).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Human adenoviruses (Ad) are nonenveloped, double-stranded DNA
viruses. They have been divided into seven species (A–G) currently
containing 52 recognized types (Benkö et al., 2000; Jones et al., 2007;
Wadell et al., 1980). Human adenoviruses have a broad spectrum of
tropism, and different types can cause the same or distinct infections.
The outer protein capsid structure mainly consists of three polypep-
tides: thehexon, thepentonbase, and theﬁber (Berk, 2005;Maizel et al.,
1968). There is one pentameric penton base with a protruding trimeric
ﬁber situated ateachof the12vertices of thevirusparticle,whilemost of
the icosahedral capsid is made up of hexons (Hong and Engler, 1996;
Valentine and Pereira, 1965; Xia et al., 1995). Themajor determinant for
attachment of Ads to host cells is the C-terminal knob domain of the
ﬁber protein (Arnberg, 2009). Ad11p and themajority of other species B
serotypes except perhaps Ad3 and Ad7 use CD46 as a cellular receptor
(Gaggar et al., 2003; Marttila et al., 2005; Segerman et al., 2003).
However, it has also been suggested recently thatAd7p andAd3 can also
bind to CD46 and use similar binding sites on the molecule as used by
other species B serotypes (Fleischli et al., 2007; Sirena et al., 2004).
CD46, also known as membrane cofactor protein (MCP), is a
complement regulatory protein that is expressed on all nucleated cells
(Riley-Vargas et al., 2004). C3b and C4b are natural ligands to CD46(Oksjoki et al., 2007). CD46 mediates their breakdown, acting as a
cofactor for serine protease factor I, and thus protects host cells from
homologous complement attack (Oksjoki et al., 2007;Riley-Vargas et al.,
2004). Other important cell surface receptors that regulate complement
activity are CR1, CR1q, CD55, and CD59 (Oksjoki et al., 2007). A number
of pathogens including human herpesvirus 6 (HHV-6), the Edmonston
strain of measles virus, bovine viral diarrhea virus (BVDV), Neisseria
gonorrheae, Neisseria meningitides, and Streptococcus pyogenes all use
CD46 as a receptor (Cattaneo, 2004). Human CD46 is alternatively
spliced into several isoforms, resulting in a varying number of
extracellular domains and two different cytoplasmatic tails, CYT1 and
CYT2 (Seya et al., 1999). CD46 seems to be constitutively recycled from
the cell surface via clathrin-coated pits and transported to perinuclear
multivesicular bodies (Crimeen-Irwin et al., 2003).
Measles virus (MV) and Ad35 binding to CD46 leads to down-
regulation of CD46 expression on the cell surface (Gill et al., 2003; Gill
et al., 2005; Russell, 2004; Sakurai et al., 2007). Binding of MV to CD46
on epithelial cells leads to rapid internalization, whereas binding of N.
gonorrheae results in shedding of CD46. The biological implications of
modulation of CD46 expression are not fully understood (Dempsey
et al., 1996; Riley-Vargas et al., 2004). Antibody crosslinking of CD46
induces macropinocytosis, followed by rapid intracellular degrada-
tion. MV-mediated downregulation of CD46 alters MHC class I or class
II presentation of antigens (Gerlier et al., 1994a,b). Binding of Ad16
and Ad35 to CD46 has been shown to mediate reduction of IL-12
levels in IFN- or lipopolysaccharide-stimulated human peripheral
blood mononuclear cells (Iacobelli-Martinez et al., 2005).
Fig. 1. Polyclonal antiserum downregulates CD46 at the cell surface. Polyclonal anti-
CD46 antiserum (1840) downregulated CD46 at the K562 cell surface. K562 cells were
incubated with this antiserum (1840) or unimmunized rabbit serum (UI serum) for 4 h
at 37 °C or on ice. Histograms show CD46 levels that were detectable at the cell surface
after incubation with antiserum. Bar graphs show the geometric means (Geo. Means) of
histograms. The data shown here are representative of two independent experiments
with duplicate samples.
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inhibits contact hypersensitivity reactions in mouse T cells, while
CD46 CYT2 increases them (Marie et al., 2002). Also, internalization of
CD46 makes cells more susceptible to complement-mediated lysis
(Marie et al., 2002; Schneider-Schaulies et al., 1996; Schnorr et al.,
1995). It has been shown recently, however, that CD59 inactivation—
or combined CD55 and CD59 inactivation—sensitizes lung cancer cell
lines to complement-mediated lysis, while CD46 inactivation does so
to a lesser extent (Ajona et al., 2007). Recently, however, reported
results showed that modiﬁed Ad35 rﬁber (Ad35rﬁber++) with
increased afﬁnity for CD46 sensitizes tumor cells of lymphoma
disease for complement-dependent cytotoxicity (Wang et al., 2010).Fig. 2. CD46 level is downregulated on the K562 cell surface by treatment with Ad11p virion
different lengths of time, 30 min, or 4 h. The results shown here are means±standard error
differences from the results of incubations with different amounts of virions/cell are shownWe set out to determine if CD46 is downregulated by binding of
Ad11p virions. Fleischli et al. (2007) have recently shown that Ad7
and Ad3 virions share a low-afﬁnity binding site on CD46 with other
CD46 binding adenoviruses. Thus, wewanted to investigate the role of
the possible low-afﬁnity interaction between Ad7p virions and CD46
in the context of CD46 downregulation. We show here using ﬂow
cytometry that cell surface CD46 levels are rapidly downregulated by
the presence of Ad11p virions. We found that speciﬁc binding
between the ﬁber knob of Ad11p and CD46 is required for down-
regulation of CD46. In addition, the cell surface levels of the closely
related complement regulatory factors CD55 and CD59 vary greatly
among cell lines used. In this regard, exposure to Ad11p virions clearly
reduced CD55 and CD59 on K562 cells but such downregulation effect
was barely discernible on A549 cells.
Results
Adenovirus 11p virions downregulate CD46 expression on the cell
surface
To determine whether CD46 levels are downregulated by Ad11p
virions, we employed a ﬂow cytometry assay that detects cell surface
CD46 levels on K562 cells (see Materials and methods). It has been
shown previously that serum crosslinking of CD46 induces down-
regulation by macropinocytosis (Crimeen-Irwin et al., 2003). To
establish that the same mechanism was present in the clone of K562
cells used in the experiments, we repeated the antibody cross-linking
experiment originally performed by Crimeen-Irwin et al. (2003). In
short, polyclonal rabbit serum against CD46 was added to K562 cells
and incubated for 4 h at 37 °C or on ice. Cells were then stripped
(Crimeen-Irwin et al., 2003), and cell surface CD46 levels were
detected by FACS after incubation with monoclonal FITC-conjugated
anti-CD46 antibody. Polyclonal rabbit antiserum (1840) to CD46
(incubated for 4 h) induced almost total downregulation of CD46 on
the K562 cell surface at 37 °C (Fig. 1). In contrast, the CD46 levels of
the control cells incubated on ice were not affected by serum
crosslinking (Fig. 1). Also unimmunized rabbit serum failed to
downregulate CD46 (Fig. 1). We then proceeded to determine
whether Ad11p virions could cause downregulation of CD46
expression on the K562 cell surface. Increasing amounts of Ad11p
virionswere added to K562 cells resuspended in 1% FCS RPMImedium
at 30 min and 4 h (37 °C) (Fig. 2). Maximal surface downregulation of
CD46 was observed after 30 min and at a concentration of 8×104
virions/cell (Fig. 2). Having established the amount of virions/cells. K562 cells were incubated with increasing amounts of virus particles per cell for two
s of means (SEM) of duplicate samples from two independent experiments. Signiﬁcant
: *Pb0.05, **Pb0.01, ***Pb0.001.
Fig. 3. Levels of CD46 on the K562 cell surface is rapidly downregulated by Ad11p virions. K562 cells were incubated with 4×104 Ad11p virus particles per cell for 5, 30 min, or 4 h at
37 °C. (a) Epiﬂuorescence images of CD46 downregulation with Ad11p were acquired on an Olympus CellR imaging station (Olympus Biosystems) equipped with an inverted
microscope (IX81; Olympus), a 100×1.4 A Planapochromat objective, and a cooled CCD camera (Orca ER; Hamamatsu Photonics). (b) The results are means±standard errors of
means (SEM) of duplicate data from two independent experiments. No virus–CD46 represents the CD46 levels on cell surfaces when no virus particles were added, and Ad11p-CD46
represents the CD46 levels on cell surfaces when virus particles were added. Signiﬁcant differences from results of incubations with no virus present (control–CD46) are shown
above each bar: *Pb0.05, **Pb0.01, ***Pb0.001.
476 D.J. Gustafsson et al. / Virology 405 (2010) 474–482needed for maximal downregulation, we then proceeded to investi-
gate the time dependency of the downregulation of CD46 expression
by Ad11p (Fig. 2).
A signiﬁcant downregulation of CD46 by Ad11p virions could be
detected already after 5 min at 37 °C, and increased in a time-
dependent fashion to reach a maximum at 4 h as seen by inspection
through an inverted microscope or by ﬂowcytometric analysisFig. 4. Downregulation of cell surface CD46 by Ad11p is also detected with different antibodi
detected with polyclonal anti-CD46 antibody (H-294) (a) or monoclonal anti-CD46 antibod
(SEM) of duplicate data from three independent experiments. No virion indicates CD46 leve
when Ad11p or Ad7p virus particles (4×104 particles per cell) were added. Signiﬁcant diffe
shown above each bar: *Pb0.05, **Pb0.01, ***Pb0.001.(Figs. 3a and b). The antibody MEM-258 was used to detect CD46 at
the cell surface after virus binding. This antibody has been shown to
interact with the SCR1-2 region of CD46. Since this is the binding
region for species B adenoviruses (Fleischli et al., 2007), we performed
additional experiments in which cell surface CD46 levels after virus
binding were detected with polyclonal antiserum to CD46 (H-294) or
monoclonal antibody (E4.3) (Materials andmethods), both antibodieses. K562 cells were incubated with Ad11p or Ad7p virions for 30 min at 37 °C. CD46 was
y (169-1-E4.3; Ancell) (b). The data shown here are means±standard errors of means
l when no virus particles were added; Ad11p virion or Ad7p virion indicates CD46 level
rences from the results of incubations with no virus present marked as control cells are
477D.J. Gustafsson et al. / Virology 405 (2010) 474–482recognize different epitopes of CD46 molecules. With the additional
poly- or monoclonal antibodies, a corresponding downregulation of
CD46 was observed 30 min after incubation with Ad11p virions
(Fig. 4). Thus, we concluded that the observed downregulation of
CD46 was not simply due to blockage of the target epitopes for the
detecting antibody as a result of virus binding (Fig. 4). In summary,
these results show that CD46 levels on the K562 cell surface is
downregulated by Ad11p virions in a dose- and time-dependent
manner.
CD46, CD55, and CD59 on K562 cells and only CD46 on A549 cells were
downregulated by Ad11p virions to a signiﬁcant extent
It has been shown previously that downregulation of CD46
expression sensitizes cells to complement-mediated lysis (Krantic
et al., 1995), and also that CD55 and CD59 are of importance for
protecting cells against complement (Ajona et al., 2007). In a recent
publication, Fleischli et al. (2007) showed that Ad3 and Ad7p bind to
CD46. We have previously shown that the ﬁber knobs of Ad7p do not
bind to CD46 in the same fashion as Ad11p ﬁber knobs (GustafssonFig. 5. (a) Cell surface levels of CD46, CD55, and CD59 on K562 and A549 cells. Filled histogram
represent cell autoﬂuorescence when isotype IgG FITC-conjugated negative control antibody
CD46 on K562 cells. Columns represent cell surface expression of CD46, CD55, or CD59 after in
The data shown here are means±standard errors of means (SEM) of duplicate samples from
virus particles were added; and Ad7p or Ad11p represents CD46, CD55, and CD59 levels whe
virus present are shown: *Pb0.05, **Pb0.01, ***Pb0.001. (c) Histograms show the levels of
30 min, 4 h or 8 h respectively. (d) Ad11p virions speciﬁcally downregulate cell surface leve
CD46, CD55, or CD59 after incubation with Ad11p or Ad7p virions (at 4×104 virions per cel
(SEM) of duplicate samples from two different experiments. No virus represents receptor lev
CD59 levels when virus particles were added. Signiﬁcant differences from results of incuba
show the levels of CD46, CD55, and CD59 on A549 cell surface after incubation with Ad11pet al., 2006). Thus, wewanted to investigate the biological signiﬁcance
of the binding afﬁnity of Ad7p for CD46. We used a ﬂow cytometry
assay to determine the effect of incubation of K562 or A549 cells with
Ad11p or Ad7p virions on the levels of CD46, CD55, and CD59 at the
cell surfaces. We began by establishing the normal control, levels of
CD46, CD55, and CD59 on K562 and A549 cells (Fig. 5a). Incubation of
K562 cells with Ad11p virions caused signiﬁcant downregulation of
CD46 at the cell surface, whereas Ad7p virions did not (Pb0.001 for
30 min, 4 h and 8 h of incubation) (Figs. 5b and c). CD55 and CD59
levels were also signiﬁcantly reduced at 4 h or 8 h, compared to
untreated K562 cells (Figs. 5b and c). Incubation of K562 cells with
Ad7p virions did not lead to any signiﬁcant downregulation of CD46,
or CD59 at 30 min, 4 h or at 8 h (PN0.05) but did downregulate CD55
to some extend at 4 h or 8 h (Figs. 5b and c).
The same experiment was then carried out with A549 cells
(Figs. 5d and e). Again, CD46 levels at the cell surface were
downregulated by Ad11p virions at 30 min, 4 h, and 8 h; however, a
general downregulation of CD55 and CD59 level was observed at the
8 h time point (Figs. 5d and e). The extent of CD59 downregulation
was smaller than that of CD46 downregulation at the same times (PC) represent cell surface expression of CD46, CD55, or CD59. Open histograms (NC)
was added. (b) Ad11p virions but not Ad7p virions downregulate cell surface levels of
cubation with Ad11p or Ad7p virions (at 4×104 virions per cell) for the indicated times.
two different experiments. No virus represents CD46, CD55, and CD59 levels when no
n virus particles were added. Signiﬁcant differences from results of incubations with no
CD46, CD55, and CD59 on K562 cell surface after incubation with Ad11p and Ad7p for
ls of CD46 on A549 cells very early in infection. Bars represent cell surface expression of
l) for the prescribed times. The data shown here are means±standard errors of means
els when no virus particles were added; and Ad7p or Ad11p represents CD46, CD55, and
tions with no virus present are shown: *Pb0.05, **Pb0.01, ***Pb0.001. (e) Histograms
and Ad7p for 30 min, 4 h, or 8 h.
Fig. 5 (continued).
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downregulation of CD46 on A549 cells at 30 min and 4 h. At 8 h,
however, there was general downregulation of CD46, CD55, and CD59
on A549 cells after incubation with either Ad11p or Ad7p virions
(Figs. 5d and e).
Binding of the Ad11p ﬁber knob to CD46 is required for downregulation
of CD46 at the cell surface
The main adenovirus-speciﬁc determinant for virus binding to the
cell surface is the ﬁber knob (Bewley et al., 1999; Philipson et al.,
1968; Stevenson et al., 1997; Valentine and Pereira, 1965). We
therefore hypothesized that the recombinant Ad11p ﬁber knob
(Ad11pwt-rFK) should be sufﬁcient to downregulate CD46 at the
cell surface. In our experiments, we also included amutant form of the
Ad11pwt-rFK (11p-R279Q-rFK) that has previously been shown not
to bind to CD46 or to bind to CD46 with an afﬁnity similar to that of
Ad7pwt-rFKs (Gustafsson et al., 2006). K562 cells were incubated for
30 min or 8 h at 37 °C with Ad11wt-rFK, Ad7pwt-rFK (Fig. 6a), or with
Ad11pwt-rFK, Ad11p-R279Q-rFK (Fig. 6b). Ad11wt-rFK but not
Ad7pwt-rFK caused signiﬁcant downregulation of CD46 on K562
cells already at 30 min and to a somewhat greater extent at 8 h
(Figs. 6a and b). Ad11p-R279Q-rFK also affected the CD46 levels when
incubated with K562 cells at 30 min and to a greater extent at 8 h
(Fig. 6b). The downregulation of CD46mediated by Ad11p-R279Q-rFK
was less prominent at both time points than that caused by Ad11wt-
rFK. In contrast, Ad7pwt-rFK did not cause any signiﬁcant CD46
downregulation at any time point. The results of this experiment
show that the presence of recombinant ﬁber knobs from wild-typeAd11p (not only whole virions) is sufﬁcient to cause downregulation
of CD46 expression. The phenomenon therefore appears to be caused
by Ad11p ﬁber knobs.
Discussion
Ad11p uses the ubiquitous CD46 molecule as a receptor for
attachment (Marttila et al., 2005; Segerman et al., 2003), the expression
ofwhich canbeupregulatedon solid tumors (Maizel et al., 1968;Russell,
2004). Furthermore, there is a low seroprevalence of Ad11p in the
general adult population. Consequently, Ad11p is a strong vector
candidate for gene therapy (Stone et al., 2005; Vogels et al., 2003). We
have also characterized the region in the recombinant ﬁber of Ad11p
that mediates binding to CD46, by mutation studies (Gustafsson et al.,
2006). These resultshavebeenveriﬁedbycocrystallization ofAd11p rFK
with CD46 (Persson et al., 2007). Binding of Ad11p to CD46 mediates a
conformational change in the SCR1 and SCR2 domains (Persson et al.,
2007). Ad35, measles virus, and the N. gonorrheae pilus induce
downregulation of CD46 after attachment (Gill et al., 2003; Krantic
et al., 1995; Sakurai et al., 2007).
Binding of Ad11p to CD46 is somewhat different fromthat of Ad35 to
CD46. The FG loop of the Ad35 ﬁber knob is closer to SCR1 of CD46 and
the IJ loop is shorter in Ad35 (Wang et al., 2007), thus being positioned
further away from SCR2 than the corresponding loop of Ad11. Also, four
important amino acid positions (Phe242, Arg279, Ser282, and Glu302)
have been identiﬁed in Ad35, whereby a mutation in any one of these
can prevent CD46binding. In contrast, only a singlemutation at position
279 (normally alsoArg) in theAd11pﬁber knob appears to be critical for
binding to CD46 (Gustafsson et al., 2006).
Fig. 5 (continued).
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and Ad7p to CD46 is plausible. We therefore set out to investigate
whether Ad11p or Ad7p can downregulate CD46 expression at 37 °C.
CD46 was found to be speciﬁcally downregulated by Ad11p virions but
not by Ad7p virions. This was observed at early stages of infection on
both A549 and K562 cells. We also found that recombinant ﬁber knobs
fromAd11p downregulate CD46 expression at the cell surface, but Ad7p
failed to signiﬁcantly downregulate CD46 at concentrations of up to
4×104 virions per cell. If Ad7p and Ad11 do indeed share CD46 as an
attachment receptor, differences in binding to CD46 could give rise to
different downstream immunomodulatory signals. SinceCD46probably
has an important role in the control of inﬂammation, this could provide
an explanation for the aggressive respiratory tract pathogenicity of
Ad7p in younger individuals and the severe urinary tract infections
causedbyAd11 in immunocompromised individuals (Astier, 2008; Choi
et al., 2006; Leen and Rooney, 2005; Manalo et al., 1971).
Since CD46 protects against autologous complement lysis of cells
(Russell, 2004), it is alsoof importance to investigate thedownregulation
of CD46 by Ad11p virions, as this adenovirus serotype maywell be used
as a vector system for gene therapy in the future.We have conﬁrmed the
expression of complement regulatory factors (CD46, CD55, and CD59)
on the surface of K562 and A549 cells. We also demonstrated that the
relative densities of the factors are similar on the cell lines studied and
the expression proﬁle is CD59NCD55NCD46, which corresponds to thelevels of these factors on pancreatic cells, oral squamous cells, and breast
carcinoma cells (Ravindranath and Shuler, 2007). We have also shown
here that Ad11p speciﬁcally downregulated CD46 expression on the
surface of K562andA549cells and apparently reduced the levels of CD55
and CD59 on K562 cells and also late on in infection of A549 cells. We
noted that bindingofAd7p toA549 cells caused apartial downregulation
of CD46, and also of CD55 and CD59. This was most prominent after 8 h
of incubation. Ad11p caused signiﬁcant downregulation of CD46 inA549
cells at 30 min but also showed the same general downregulation of
CD46, CD55, and CD59 after 8 h as compared to Ad7p. Since both
serotypes replicate in A549 cells, we hypothesize that the experimental
conditions and lytic infection cycle of the virus leads to a general
downregulation of receptors at 8 h. The mutant ﬁber knobs of Ad11p
(Ad11p-R279Q-rFK) were also found to downregulate CD46 to some
extent but not as efﬁciently as the downregulation mediated by wild-
type recombinant ﬁber knobs (Ad11pwt-rFKs). We propose that this
may be a function of possible differences in afﬁnity for CD46, Ad7pwt
ﬁber knobs having the lowest afﬁnity and Ad11p-R279Q-rFK having a
somewhathigher afﬁnity butnot being able tobind toCD46 as efﬁciently
as Ad11pwt ﬁber knobs while still perhaps managing to create the
necessary conformational change or dimerization of the receptor
required for down-regulation.
Studies have shown that downregulation of CD46 expressionmakes
cells more exposed to complement challenge (Schneider-Schaulies
et al., 1996). CD46 acts as a cofactor for inactivation and cleavage of C3b
and C4b by serine protease factor I (Russell, 2004; Schneider-Schaulies
et al., 1996); it thus brings about inhibition of the complement cascade
by preventing an upstream event leading to C5b formation. CD55
accelerates the decay of C3 and C5 convertase, thus inhibiting the
formation of C3b and C5b (Oksjoki et al., 2007). CD59 in turn prevents
assembly of themembrane attack complex (MAC) (Oksjoki et al., 2007).
In a recent publication, there is some evidence for a partial compen-
sationof the protective function of CD46byCD55 andCD59 (Ajona et al.,
2007). This might suggest that the Ad11p-mediated downregulation of
CD46 does not per se render the host cell totally unprotected against
complement challenge. CD46 expression is upregulated on breast
cancer cells, while the levels of CD55 and CD59 are downregulated
(Madjd et al., 2005; Rushmere et al., 2004). Thiswould in theory provide
a tumor type with complement regulation resting mainly on CD46
levels. It is however interesting that binding of Ad11p to K562 cells does
signiﬁcantly affect the cell surface levels of CD55 and CD59, as this
would make the host cell sensitive to cell lysis mediated by the
complement system. Thus, downregulation of CD46 after infection
could sensitize certain tumor cells to complement-mediated lysis,
providing an additional tumor-lytic effect. With the high accessibility of
breast tumors for in situ administration, the use of adenovirus vectors as
novel adjuvant therapy seems at least theoretically feasible.
In this paper, we have shown that Ad11p virions and recombinant
ﬁber knobs downregulate CD46 expression in a time- and dose-
dependent manner. We have also demonstrated that the cell surface
levelsof CD55andCD59down-regulationvarygreatly invarious cell lines
and at different time points p.i. Ad11p virions induced a more effective
downregulation in the K562 cells of hematopoietic origin than in the
epithelial A549 cells. These results are in agreement with the results of
previous studiesondownregulationofCD46expressionbyAd35(Sakurai
i et al., 2007), whereas themoderate effect with Ad7p perhaps provides a
clue to the biological relevance of low-afﬁnity binding to CD46.
Materials and methods
Cells, viruses, antibodies, and recombinant ﬁber knobs (rFKs)
(i) Cells. Human respiratory epithelial A549 cells were grown in
Dulbecco's modiﬁed Eagle's medium (DMEM; Sigma Chemical
Co., St. Louis, MO) containing 5% fetal calf serum (FCS), HEPES,
and penicillin–streptomycin (all from Sigma). K562 cells were
Fig. 5 (continued).
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blast crisis, and the cells are multipotential blasts that
spontaneously can differentiate into progenitors of the eryth-
rocytic, granulocytic, and monocytic series (Lozzio et al., 1981).
K562 cells were grown in RPMI (Sigma) containing 10% fetal
calf serum (FCS), HEPES, and penicillin–streptomycin.
(ii) Viruses. Adenovirus type 11p (prototype strain Slobitski) and 7p
(prototype strain Gomen)were grown in A549 cells and puriﬁed
in CsCl gradients as previously described (Mei et al., 1998). The
quality of each viral preparation was controlled by a ratio of
infectiousparticlesversusphysical particles (IP/PP). In this study,
the ratio of IP/PP was 1:72 for Ad11p and 1:23 for Ad7p viral
preparation. Virion concentration was determined by spectro-
photometry (at 260 and 330 nm) according to the following: one
unit of absorbance at A260−A330 is equivalent to 1012 particles/
ml or 280 μg of viral particles per milliliter (Segerman et al.,
2000). Both viruseswere typedaccording to theirDNA restriction
enzyme patterns as previously described (Adrian et al., 1986).
(iii) Antibodies. The 1840 rabbit antiserum, raised against the
recombinant extracellular domain of CD46, was a kind gift from
Dr. Sarah M. Russell (Peter MacCallum Cancer Center, Tres-
cowthick Research Laboratories, East Melbourne, Australia).
Unimmunized rabbit serum was obtained from rabbit 471 on
January 29, 1969 (Prof. G Wadell, Department of Virology,
Umeå University, Sweden). Mouse monoclonal MEM-258-FITC
antibody against human CD46 (Biolegend, San Diego, CA),
mouse monoclonal antibody conjugated with FITC against anti-
human CD46 (169-1-E4.3; Ancell); polyclonal anti CD46
antibody H-294 (Santa Cruz Biotechnology, Inc.), mouse
monoclonal FITC-conjugated antibody against human CD55,
CD59 (BD Pharmigen, San Diego, CA), and mouse monoclonal
isotype IgG FITC-conjugated control antibody, X0927 (DAKO A/S), were all used according to the manufacturers' recommen-
dations in concentrations described below.
(iv) Recombinant ﬁber knobs (rFKs). DNA isolation andmanipula-
tion were performed by standard techniques. DNA fragments
encoding the ﬁber knob of Ad11p and Ad7p were ampliﬁed by
PCR with primers described previously (Gustafsson et al., 2006),
preserving the last shaftmotif and the trimerization signal. Point-
mutated constructs of Ad11p-R279Q-rFK were created using the
Quick Change kit (Stratagene, La Jolla, CA) according to the
manufacturer's guidelines, using previously described primers.
All PCR products were cloned into the pET-3d expression vector
(Novagen, Madison,WI) containing an N-terminal His6 tagmotif
by using previously described methods (Gustafsson et al., 2006).
The identity of the construct was conﬁrmed by nucleotide
sequence analysis. Proteins were expressed in Escherichia coli
(strain BL21) and puriﬁed using nitrilotriacetic acid (NTA)
agarose according to the guidelines of themanufacturer (Qiagen,
Hilden, Germany). All recombinant proteins were visualized by
Coomassie brilliant blue staining of both denaturing (SDS–) and
native polyacrylamide gels (not shown).
Flow cytometric assay of cell surface levels of CD46, CD55, and CD59
Adherent A549 cells were harvested with phosphate-buffered
saline (PBS) containing 0.05% (wt./vol.) EDTA. Cells were allowed to
recover for 1 h in DMEM containing 5% FCS (5% FCS DMEM) under
constant agitation and they were then washed twice with 1% FCS
DMEM. Suspension cultures of K562 cells were harvested by
centrifugation and washed twice with 1% FCS RPMI medium. They
were then resuspended at 4×104 cells per tube, in 1.5-ml eppendorf
tubes. After centrifugation at 290×g for 5 min at 4 °C or 37 °C, the
supernatant was removed, and virus suspension or ﬁber knob protein
Fig. 6. Downregulation of CD46 levels at the cell surface by Ad11p requires binding by Ad11p recombinant ﬁber knobs. Ad11pwt-rFK was compared with Ad7pwt-rFK, or Ad11pwt-
rFK was compared Ad11p-R279Q-rFK ﬁber knobs (5 pg/cell). The rFKs were incubated with K562 cells at 37 °C for 30 min or for 8 h. No virus indicates no Ad11pwt-rFK, No Ad7pwt-
rFK, or No Ad11p-R279Q-rFK denote K562 cells incubated without ﬁber knobs, while Ad11pwt-rFK, Ad7pwt-rFK, or Ad11p-R279Q-rFK denotes K562 cells incubated with different
ﬁber knobs. The results are means±standard errors of means (SEM) of duplicate data from two representative experiments. Signiﬁcant differences from results with No Ad11pwt-
rFK, No Ad7pwt-rFK, or No Ad11p-R279Q-rFK are shown: *Pb0.05, **Pb0.01, ***Pb0.001.
481D.J. Gustafsson et al. / Virology 405 (2010) 474–482was added at selected concentrations in a total volume of 200 μl
(RPMI or DMEM with 1% FCS). After incubation of the tubes at 37 °C
with constant agitation for the described time intervals, the cells were
pelleted at 290×g for 5 min at 4 °C or 37 °C and washed with 150 μl of
1% FCS PBS. The cells were then incubated for 30 min on ice with FITC-
conjugated mouse monoclonal antibodies against CD46, CD55, CD59
diluted 1:50 (CD46, CD55, isotype IgG) or 1:25 (CD59) in 100 μl of 1%
FCS PBS per tube. Thereafter, the cells were washed as described
above and analyzed by FACScan ﬂow cytometer (Becton Dickinson).
The measurements consisted of 10,000 events per sample. Data were
then analyzed using the LYSYS II software (Becton Dickinson).
For experiments with rabbit polyclonal antibody against CD46 (H-
294) or rabbit polyclonal antiserum (1840), the same procedure was
followed until cells were pelleted at 290×g and washed with FLOW
buffer, containing 1% (wt./vol.) glucose (Glc), 0.01% NaN3 (wt./vol.), and
1% paraformaldehyde (PFA) (wt./vol.) in PBS, pH 7.4). H-294 or 1840
antiserum was then added at dilutions of 1:100 or 2 μg/ml, respectively,
and incubated for 30 min on ice. The cell pelletswerewashedwith FLOW
buffer and then resuspended in 300 μl of FITC-conjugated swine anti-
rabbit IgG diluted 1:40 (Dako Cytomation, Danmark A/B) in FLOWbuffer
and incubated for 30 min in the dark on a shaker. The cells were washed
and analyzed by a FACScan ﬂow cytometer as described above. Control
experiments ofCD46downregulationby1840antiserumwereperformed
as described above with the exception that cells were incubated with
antiserum (1840 or unimmunized rabbit serum) for 4 h, washed, and
then stripped of antibodies according to previously established protocols
(Crimeen-Irwin et al., 2003).
Statistical analysis
Statistical analyses were performedwith GraphPad Prism software
version 4.03 (GraphPad Software, La Jolla, CA). The effect of Ad11pand Ad7p viron or ﬁber knob (FK) on the CD46 levels was evaluated
by Student's t test, namely two-sample (unpaired) t-test.Acknowledgments
We thank Dr. Sarah M. Russell for the kind gift of polyclonal
antiserum 1840. We also thank Dr. Bengt Hallberg for interesting
discussions and Mikael Sellin for helping us with the inverted
microscope (IX81; Olympus). This project was ﬁnanced by grants
from the Swedish Science Council, no. K2007-56X-05688-283, from
the Swedish Cancer Foundation, no. 1547-B06-18XBC, and from the
Kempe Foundation at Umeå University.References
Adrian, T., Wadell, G., Hierholzer, J.C., Wigand, R., 1986. DNA restriction analysis of
adenovirus prototypes 1 to 41. Arch. Virol. 91 (3–4), 277–290.
Ajona, D., Hsu, Y.F., Corrales, L., Montuenga, L.M., Pio, R., 2007. Down-regulation of
human complement factor H sensitizes non-small cell lung cancer cells to
complement attack and reduces in vivo tumor growth. J. Immunol. 178 (9),
5991–5998.
Arnberg, N., 2009. Adenovirus receptors: implications for tropism, treatment and
targeting. Rev. Med. Virol. 19 (3), 165–178.
Astier, A.L., 2008. T-cell regulation by CD46 and its relevance in multiple sclerosis.
Immunology 124 (2), 149–154.
Benkö, M., Harrach, B., Russell, W.C., 2000. Family adenoviridae. Virus Taxonomy.
Academic Press, Inc, San Diego, CA, pp. 227–238.
Berk, A.J., 2005. Recent lessons in gene expression, cell cycle control, and cell biology
from adenovirus. Oncogene 24 (52), 7673–7685.
Bewley, M.C., Springer, K., Zhang, Y.B., Freimuth, P., Flanagan, J.M., 1999. Structural
analysis of the mechanism of adenovirus binding to its human cellular receptor,
CAR. Science 286 (5444), 1579–1583.
Cattaneo, R., 2004. Four viruses, two bacteria, and one receptor: Membrane cofactor
protein (CD46) as pathogens' magnet. J. Virol. 78 (9), 4385–4388.
482 D.J. Gustafsson et al. / Virology 405 (2010) 474–482Choi, E.H., Lee, H.J., Kim, S.J., Eun, B.W., Kim, N.H., Lee, J.A., Lee, J.H., Song, E.K., Kim, S.H.,
2006. Ten-year analysis of adenovirus type 7 molecular epidemiology in Korea,
1995–2004: Implication of ﬁber diversity. J. Clin. Virol. 35 (4), 388–393.
Crimeen-Irwin, B., Ellis, S., Christiansen, D., Ludford-Menting, M.J., Milland, J., Lanteri,
M., Loveland, B.E., Gerlier, D., Russell, S.M., 2003. Ligand binding determines
whether CD46 is internalized by clathrin-coated pits or macropinocytosis. J. Biol.
Chem. 278 (47), 46927–46937.
Dempsey, P.W., Allison, M.E., Akkaraju, S., Goodnow, C.C., Fearon, D.T., 1996. C3d of
complement as a molecular adjuvant: Bridging innate and acquired immunity.
Science 271 (5247), 348–350.
Fleischli, C., Sirena, D., Lesage, G., Havenga, M.J., Cattaneo, R., Greber, U.F., Hemmi, S.,
2007. Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on
the membrane cofactor protein CD46 receptor. J. Gen. Virol. 88 (Pt 11), 2925–2934.
Gaggar, A., Shayakhmetov, D.M., Lieber, A., 2003. CD46 is a cellular receptor for group B
adenoviruses. Nat. Med. 9 (11), 1408–1412.
Gerlier, D., Trescol-Biemont, M.C., Varior-Krishnan, G., Naniche, D., Fugier-Vivier, I.,
Rabourdin-Combe, C., 1994a. Efﬁcient major histocompatibility complex class II-
restricted presentation of measles virus relies on hemagglutinin-mediated
targeting to its cellular receptor human CD46 expressed by murine B cells. J. Exp.
Med. 179 (1), 353–358.
Gerlier, D., Trescol-Biemont, M.C., Varior-Krishnan, G., Naniche, D., Fugier-Vivier, I.,
Rabourdin-Combe, C., 1994b. Efﬁcient MHC class II-restricted presentation of
measles virus to T cells relies on its targeting to its cellular receptor human CD46
and involves an endosomal pathway. Cell Biol. Int. 18 (5), 315–320.
Gill, D.B., Koomey, M., Cannon, J.G., Atkinson, J.P., 2003. Down-regulation of CD46 by
piliated Neisseria gonorrhoeae. J. Exp. Med. 198 (9), 1313–1322.
Gill, D.B., Spitzer, D., Koomey, M., Heuser, J.E., Atkinson, J.P., 2005. Release of host-
derived membrane vesicles following pilus-mediated adhesion of Neisseria
gonorrhoeae. Cell. Microbiol. 7 (11), 1672–1683.
Gustafsson, D.J., Segerman, A., Lindman, K., Mei, Y.F., Wadell, G., 2006. The Arg279Gln
[corrected] substitution in the adenovirus type 11p (Ad11p) ﬁber knob abolishes
EDTA-resistant binding to A549 and CHO-CD46 cells, converting the phenotype to
that of Ad7p. J. Virol. 80 (4), 1897–1905.
Hong, J.S., Engler, J.A., 1996. Domains required for assembly of adenovirus type 2 ﬁber
trimers. J. Virol. 70 (10), 7071–7078.
Iacobelli-Martinez, M., Nepomuceno, R.R., Connolly, J., Nemerow, G.R., 2005. CD46-
utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinﬂamma-
tory cytokines. J. Virol. 79 (17), 11259–11268.
Jones II, M.S., Harrach, B., Ganac, R.D., Gozum, M.M., Dela Cruz, W.P., Riedel, B., Pan, C.,
Delwart, E.L., Schnurr, D.P., 2007. New adenovirus species found in a patient
presenting with gastroenteritis. J. Virol. 81 (11), 5978–5984.
Krantic, S., Gimenez, C., Rabourdin-Combe, C., 1995. Cell-to-cell contact via measles
virus haemagglutinin–CD46 interaction triggers CD46 downregulation. J. Gen.
Virol. 76 (Pt 11), 2793–2800.
Leen, A.M., Rooney, C.M., 2005. Adenovirus as an emerging pathogen in immunocom-
promised patients. Br. J. Haematol. 128 (2), 135–144.
Lozzio, B.B., Lozzio, C.B., Bamberger, E.G., Feliu, A.S., 1981. Amultipotential leukemia cell
line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 166 (4), 546–550.
Madjd, Z., Durrant, L.G., Pinder, S.E., Ellis, I.O., Ronan, J., Lewis, S., Rushmere, N.K.,
Spendlove, I., 2005. Do poor-prognosis breast tumours express membrane cofactor
proteins (CD46)? Cancer Immunol. Immunother. 54 (2), 149–156.
Maizel Jr., J.V., White, D.O., Scharff, M.D., 1968. The polypeptides of adenovirus: I.
Evidence for multiple protein components in the virion and a comparison of types
2, 7A, and 12. Virology 36 (1), 115–125.
Manalo, D., Mufson, M.A., Zollar, L.M., Mankad, V.N., 1971. Adenovirus infection in acute
hemorrhagic cystitis. A study in 25 children. Am. J. Dis. Child. 121 (4), 281–285.
Marie, J.C., Astier, A.L., Rivailler, P., Rabourdin-Combe, C., Wild, T.F., Horvat, B., 2002.
Linking innate and acquired immunity: divergent role of CD46 cytoplasmic
domains in T cell induced inﬂammation. Nat. Immunol. 3 (7), 659–666.
Marttila, M., Persson, D., Gustafsson, D., Liszewski, M.K., Atkinson, J.P., Wadell, G.,
Arnberg, N., 2005. CD46 is a cellular receptor for all species B adenoviruses except
types 3 and 7. J. Virol. 79 (22), 14429–14436.
Mei, Y.F., Lindman, K., Wadell, G., 1998. Two closely related adenovirus genome types
with kidney or respiratory tract tropism differ in their binding to epithelial cells of
various origins. Virology 240 (2), 254–266.
Oksjoki, R., Kovanen, P.T., Meri, S., Pentikainen, M.O., 2007. Function and regulation of
the complement system in cardiovascular diseases. Front. Biosci. 12, 4696–4708.Persson, B.D., Reiter, D.M., Marttila, M., Mei, Y.F., Casasnovas, J.M., Arnberg, N., Stehle, T.,
2007. Adenovirus type 11 binding alters the conformation of its receptor CD46. Nat.
Struct. Mol. Biol. 14 (2), 164–166.
Philipson, L., Lonberg-Holm, K., Pettersson, U., 1968. Virus–receptor interaction in an
adenovirus system. J. Virol. 2 (10), 1064–1075.
Ravindranath, N.M., Shuler, C., 2007. Cell-surface density of complement restric-
tion factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus
other solid tumors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103
(2), 231–239.
Riley-Vargas, R.C., Gill, D.B., Kemper, C., Liszewski, M.K., Atkinson, J.P., 2004. CD46:
expanding beyond complement regulation. Trends Immunol. 25 (9), 496–503.
Rushmere, N.K., Knowlden, J.M., Gee, J.M., Harper, M.E., Robertson, J.F., Morgan, B.P.,
Nicholson, R.I., 2004. Analysis of the level of mRNA expression of the membrane
regulators of complement, CD59, CD55 and CD46, in breast cancer. Int. J. Cancer 108
(6), 930–936.
Russell, S., 2004. CD46: a complement regulator and pathogen receptor that mediates
links between innate and acquired immune function. Tissue Antigens 64 (2),
111–118.
Sakurai, F., Akitomo, K., Kawabata, K., Hayakawa, T., Mizuguchi, H., 2007. Down-
regulation of human CD46 by adenovirus serotype 35 vectors. Gene Ther. 14 (11),
912–919.
Schneider-Schaulies, J., Schnorr, J.J., Schlender, J., Dunster, L.M., Schneider-Schaulies, S.,
ter Meulen, V., 1996. Receptor (CD46) modulation and complement-mediated lysis
of uninfected cells after contact with measles virus-infected cells. J. Virol. 70 (1),
255–263.
Schnorr, J.J., Dunster, L.M., Nanan, R., Schneider-Schaulies, J., Schneider-Schaulies, S., ter
Meulen, V., 1995. Measles virus-induced down-regulation of CD46 is associated
with enhanced sensitivity to complement-mediated lysis of infected cells. Eur. J.
Immunol. 25 (4), 976–984.
Segerman, A., Mei, Y.F., Wadell, G., 2000. Adenovirus types 11p and 35p show high
binding efﬁciencies for committed hematopoietic cell lines and are infective to
these cell lines. J. Virol. 74 (3), 1457–1467.
Segerman, A., Atkinson, J.P., Marttila, M., Dennerquist, V., Wadell, G., Arnberg, N., 2003.
Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77 (17), 9183–9191.
Seya, T., Hirano, A., Matsumoto, M., Nomura, M., Ueda, S., 1999. Human membrane
cofactor protein (MCP, CD46): multiple isoforms and functions. Int. J. Biochem. Cell
Biol. 31 (11), 1255–1260.
Sirena, D., Lilienfeld, B., Eisenhut, M., Kalin, S., Boucke, K., Beerli, R.R., Vogt, L., Ruedl, C.,
Bachmann, M.F., Greber, U.F., Hemmi, S., 2004. The human membrane cofactor
CD46 is a receptor for species B adenovirus serotype 3. J. Virol. 78 (9), 4454–4462.
Stevenson, S.C., Rollence, M., Marshall-Neff, J., McClelland, A., 1997. Selective targeting
of human cells by a chimeric adenovirus vector containing a modiﬁed ﬁber protein.
J. Virol. 71 (6), 4782–4790.
Stone, D., Ni, S., Li, Z.Y., Gaggar, A., DiPaolo, N., Feng, Q., Sandig, V., Lieber, A., 2005.
Development and assessment of human adenovirus type 11 as a gene transfer
vector. J. Virol. 79 (8), 5090–5104.
Valentine, R.C., Pereira, H.G., 1965. Antigens and structure of the adenovirus. J. Mol. Biol.
13 (1), 13–20.
Vogels, R., Zuijdgeest, D., van Rijnsoever, R., Hartkoorn, E., Damen, I., de Bethune, M.P.,
Kostense, S., Penders, G., Helmus, N., Koudstaal, W., Cecchini, M., Wetterwald, A.,
Sprangers, M., Lemckert, A., Ophorst, O., Koel, B., van Meerendonk, M., Quax, P.,
Panitti, L., Grimbergen, J., Bout, A., Goudsmit, J., Havenga, M., 2003. Replication-
deﬁcient human adenovirus type 35 vectors for gene transfer and vaccination:
efﬁcient human cell infection and bypass of preexisting adenovirus immunity.
J. Virol. 77 (15), 8263–8271.
Wadell, G., Hammarskjold, M.L., Winberg, G., Varsanyi, T.M., Sundell, G., 1980. Genetic
variability of adenoviruses. Ann. NY Acad. Sci. 354, 16–42.
Wang, H., Liaw, Y.C., Stone, D., Kalyuzhniy, O., Amiraslanov, I., Tuve, S., Verlinde, C.L.,
Shayakhmetov, D., Stehle, T., Rofﬂer, S., Lieber, A., 2007. Identiﬁcation of CD46
binding sites within the adenovirus serotype 35 ﬁber knob. J. Virol. 81 (23),
12785–12792.
Wang, H., Liu, Y., Li, Z.Y., Fan, X., Hemminki, A., Lieber, A., 2010. A recombinant
adenovirus type 35 ﬁber knob protein sensitizes lymphoma cells to rituximab
therapy. Blood 115 (3), 592–600.
Xia, D., Henry, L., Gerard, R.D., Deisenhofer, J., 1995. Structure of the receptor binding
domain of adenovirus type 5ﬁber protein. Curr. Top.Microbiol. Immunol. 199 (Pt 1),
39–46.
